{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:00:58Z","timestamp":1773154858628,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00595-024-02816-y","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T17:48:45Z","timestamp":1709833725000},"page":"995-1004","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of the neutrophil-to-lymphocyte ratio on patients with locally advanced non-small cell lung cancer who suffer radiation pneumonitis during the course of induction chemoradiotherapy followed by surgery"],"prefix":"10.1007","volume":"54","author":[{"given":"Yujiro","family":"Kubo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5330-5460","authenticated-orcid":false,"given":"Hiromasa","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Shien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Suzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaroh","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichiro","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniaki","family":"Katsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Hiraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyuki","family":"Kiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Toyooka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"2816_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"2816_CR2","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ejca.2021.07.039","volume":"157","author":"T Dyba","year":"2021","unstructured":"Dyba T, Randi G, Bray F, Martos C, Giusti F, Nicholson N, et al. The European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer. 2021;157:308\u201347.","journal-title":"Eur J Cancer"},{"key":"2816_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fonc.2017.00281","volume":"7","author":"DJ Sher","year":"2017","unstructured":"Sher DJ. Neoadjuvant chemoradiotherapy for stage III non-small cell lung cancer. Front Oncol. 2017;7:281.","journal-title":"Front Oncol"},{"key":"2816_CR4","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/S0140-6736(13)62159-5","volume":"383","author":"NSCLC Meta-analysis Collaborative Group","year":"2014","unstructured":"NSCLC Meta-analysis Collaborative Group. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data. Lancet. 2014;383:1561\u201371.","journal-title":"Lancet"},{"key":"2816_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0140-6736(09)60737-6","volume":"374","author":"KS Albain","year":"2009","unstructured":"Albain KS, Swann RS, Rusch VW, Turrisi AT 3rd, Shepherd FA, Smith C, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet. 2009;374:379\u201386.","journal-title":"Lancet"},{"key":"2816_CR6","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/icvts\/ivs412","volume":"15","author":"S Toyooka","year":"2012","unstructured":"Toyooka S, Kiura K, Shien K, Katsui K, Hotta K, Kanazawa S, et al. Induction chemoradiotherapy is superior to induction chemotherapy for the survival of non-small-cell lung cancer patients with pathological mediastinal lymph node metastasis. Interact Cardiovasc Thorac Surg. 2012;15:954\u201360.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2816_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/icvts\/ivs028","volume":"14","author":"S Toyooka","year":"2012","unstructured":"Toyooka S, Kiura K, Takemoto M, Oto T, Takigawa N, Fujiwara T, et al. Long-term outcome of induction chemoradiotherapy with docetaxel and cisplatin followed by surgery for non-small-cell lung cancer with mediastinal lymph node metastasis. Interact Cardiovasc Thorac Surg. 2012;14:565\u20139.","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2816_CR8","doi-asserted-by":"publisher","first-page":"967","DOI":"10.7150\/jca.18000","volume":"8","author":"F Peng","year":"2017","unstructured":"Peng F, Hu D, Lin X, Chen G, Liang B, Li C, et al. The monocyte to red blood cell count ratio is a strong predictor of postoperative survival in colorectal cancer patients: the Fujian prospective investigation of cancer (FIESTA) study. J Cancer. 2017;8:967\u201375.","journal-title":"J Cancer"},{"key":"2816_CR9","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.3892\/ol.2016.4216","volume":"11","author":"ZY Zou","year":"2016","unstructured":"Zou ZY, Liu HL, Ning N, Li SY, Du XH, Li R. Clinical significance of pre-operative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancer. Oncol Lett. 2016;11:2241\u20138.","journal-title":"Oncol Lett"},{"key":"2816_CR10","doi-asserted-by":"publisher","first-page":"12493","DOI":"10.1038\/srep12493","volume":"5","author":"XB Gu","year":"2015","unstructured":"Gu XB, Tian T, Tian XJ, Zhang XJ. Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis. Sci Rep. 2015;5:12493.","journal-title":"Sci Rep"},{"key":"2816_CR11","doi-asserted-by":"publisher","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, McNamara MG, \u0160eruga B, Vera-Badillo FE, Aneja P, Oca\u00f1a A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:dju124.","journal-title":"J Natl Cancer Inst"},{"key":"2816_CR12","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1245\/s10434-014-4021-y","volume":"22","author":"G Luo","year":"2015","unstructured":"Luo G, Guo M, Liu Z, Xiao Z, Jin K, Long J, et al. Blood neutrophil-lymphocyte ratio predicts survival in patients with advanced pancreatic cancer treated with chemotherapy. Ann Surg Oncol. 2015;22:670\u20136.","journal-title":"Ann Surg Oncol"},{"key":"2816_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00595-020-02093-5","volume":"51","author":"H Yamamoto","year":"2021","unstructured":"Yamamoto H, Namba K, Yamamoto H, Toji T, Soh J, Shien K, et al. The neutrophil-to-lymphocyte ratio as a novel independent prognostic factor for multiple metastatic lung tumors from various sarcomas. Surg Today. 2021;51:127\u201335.","journal-title":"Surg Today"},{"key":"2816_CR14","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.2217\/fon-2017-0659","volume":"14","author":"D Guo","year":"2018","unstructured":"Guo D, Han A, Jing W, Chen D, Jin F, Li M, et al. Preoperative to postoperative change in neutrophil-to-lymphocyte ratio predict survival in colorectal cancer patients. Future Oncol. 2018;14:1187\u201396.","journal-title":"Future Oncol"},{"key":"2816_CR15","doi-asserted-by":"publisher","first-page":"6529","DOI":"10.2147\/OTT.S117290","volume":"9","author":"F Jin","year":"2016","unstructured":"Jin F, Han A, Shi F, Kong L, Yu J. The postoperative neutrophil-to-lymphocyte ratio and changes in this ratio predict survival after the complete resection of stage I non-small cell lung cancer. Onco Targets Ther. 2016;9:6529\u201337.","journal-title":"Onco Targets Ther"},{"key":"2816_CR16","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1245\/s10434-021-09690-9","volume":"28","author":"S Tsudaka","year":"2021","unstructured":"Tsudaka S, Yamamoto H, Sato H, Katsui K, Suzawa K, Shien K, et al. Prognostic significance of neutrophil-to-lymphocyte ratio in locally advanced non-small-cell lung cancer treated with trimodality therapy. Ann Surg Oncol. 2021;28:4880\u201390.","journal-title":"Ann Surg Oncol"},{"key":"2816_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11604-023-01482-3","volume":"42","author":"J Shan","year":"2023","unstructured":"Shan J, Xie X, Gu B, Sun X, Liu H. Inflammation index predicts radiation-induced lung injury and prognosis in lung tumors treated with stereotactic body radiation therapy. Jpn J Radiol. 2023;42:102\u20138.","journal-title":"Jpn J Radiol"},{"key":"2816_CR18","doi-asserted-by":"publisher","first-page":"81387","DOI":"10.18632\/oncotarget.19032","volume":"8","author":"WY Pan","year":"2017","unstructured":"Pan WY, Bian C, Zou GL, Zhang CY, Hai P, Zhao R, et al. Combing NLR, V20 and mean lung dose to predict radiation induced lung injury in patients with lung cancer treated with intensity modulated radiation therapy and chemotherapy. Oncotarget. 2017;8:81387\u201393.","journal-title":"Oncotarget"},{"key":"2816_CR19","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1111\/crj.12660","volume":"12","author":"YH Lee","year":"2018","unstructured":"Lee YH, Choi HS, Jeong H, Kang KM, Song JH, Lee WS, et al. Neutrophil-lymphocyte ratio and a dosimetric factor for predicting symptomatic radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent chemoradiotherapy. Clin Respir J. 2018;12:1264\u201373.","journal-title":"Clin Respir J"},{"key":"2816_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/jjco\/hyac034","volume":"52","author":"J Eba","year":"2022","unstructured":"Eba J, Nakamura K. Overview of the ethical guidelines for medical and biological research involving human subjects in Japan. Jpn J Clin Oncol. 2022;52:539\u201344.","journal-title":"Jpn J Clin Oncol"},{"key":"2816_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39\u201351.","journal-title":"J Thorac Oncol"},{"key":"2816_CR22","volume-title":"AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al. AJCC cancer staging manual. 8th ed. Cham: Springer; 2017.","edition":"8"},{"key":"2816_CR23","volume-title":"TNM classification of malignant tumours","author":"JD Brierley","year":"2017","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 8th ed. Oxford: Wiley; 2017.","edition":"8"},{"key":"2816_CR24","unstructured":"U.S. Department of Health and Human Services NIH, National Cancer Institute,. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf. Accessed 25 Dec 2022."},{"key":"2816_CR25","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/sj.bjc.6601624","volume":"90","author":"H Katayama","year":"2004","unstructured":"Katayama H, Ueoka H, Kiura K, Tabata M, Kozuki T, Tanimoto M, et al. Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer. Br J Cancer. 2004;90:979\u201384.","journal-title":"Br J Cancer"},{"key":"2816_CR26","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.21037\/jtd.2017.08.87","volume":"9","author":"H Torigoe","year":"2017","unstructured":"Torigoe H, Soh J, Tomida S, Namba K, Sato H, Katsui K, et al. Induction chemoradiotherapy using docetaxel and cisplatin with definitive-dose radiation followed by surgery for locally advanced non-small cell lung cancer. J Thorac Dis. 2017;9:3076\u201386.","journal-title":"J Thorac Dis"},{"key":"2816_CR27","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1186\/s12885-019-6359-9","volume":"19","author":"K Katsui","year":"2019","unstructured":"Katsui K, Ogata T, Watanabe K, Katayama N, Soh J, Kuroda M, et al. Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis. BMC Cancer. 2019;19:1144.","journal-title":"BMC Cancer"},{"key":"2816_CR28","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jtcvs.2006.12.039","volume":"133","author":"H Yokomise","year":"2007","unstructured":"Yokomise H, Gotoh M, Okamoto T, Yamamoto Y, Ishikawa S, Nakashima T, et al. Induction chemoradiotherapy (carboplatin-taxane and concurrent 50-Gy radiation) for bulky cN2, N3 non-small cell lung cancer. J Thorac Cardiovasc Surg. 2007;133:1179\u201385.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2816_CR29","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transpl. 2013;48:452\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"2816_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.athoracsur.2020.07.068","volume":"112","author":"J Soh","year":"2021","unstructured":"Soh J, Sugimoto S, Namba K, Miura A, Shiotani T, Yamamoto H, et al. Chronic lung injury after trimodality therapy for locally advanced non-small cell lung cancer. Ann Thorac Surg. 2021;112:279\u201388.","journal-title":"Ann Thorac Surg"},{"key":"2816_CR31","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00595-020-01960-5","volume":"50","author":"S Sugimoto","year":"2020","unstructured":"Sugimoto S, Soh J, Suzawa K, Miyoshi K, Otani S, Yamamoto H, et al. Pulmonary aspergillosis as a late complication after surgery for locally advanced non-small cell lung cancer treated with induction chemoradiotherapy. Surg Today. 2020;50:863\u201371.","journal-title":"Surg Today"},{"key":"2816_CR32","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","volume":"377","author":"SJ Antonia","year":"2017","unstructured":"Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, et al. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. N Engl J Med. 2017;377:1919\u201329.","journal-title":"N Engl J Med"},{"key":"2816_CR33","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","volume":"386","author":"PM Forde","year":"2022","unstructured":"Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM, et al. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer. N Engl J Med. 2022;386:1973\u201385.","journal-title":"N Engl J Med"},{"key":"2816_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.radonc.2004.02.015","volume":"71","author":"G Rodrigues","year":"2004","unstructured":"Rodrigues G, Lock M, D\u2019Souza D, Yu E, Van Dyk J. Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer\u2013a systematic review. Radiother Oncol. 2004;71:127\u201338.","journal-title":"Radiother Oncol"},{"key":"2816_CR35","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ijrobp.2012.04.043","volume":"85","author":"DA Palma","year":"2013","unstructured":"Palma DA, Senan S, Tsujino K, Barriger RB, Rengan R, Moreno M, et al. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis. Int J Radiat Oncol Biol Phys. 2013;85:444\u201350.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2816_CR36","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s00066-016-1021-9","volume":"192","author":"S Takahashi","year":"2016","unstructured":"Takahashi S, Go T, Kasai Y, Yokomise H, Shibata T. Relationship between dose\u2013volume parameters and pulmonary complications after neoadjuvant chemoradiotherapy followed by surgery for lung cancer. Strahlenther Onkol. 2016;192:658\u201367.","journal-title":"Strahlenther Onkol"},{"key":"2816_CR37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.chest.2019.03.033","volume":"156","author":"AN Hanania","year":"2019","unstructured":"Hanania AN, Mainwaring W, Ghebre YT, Hanania NA, Ludwig M. Radiation-induced lung injury: assessment and management. Chest. 2019;156:150\u201362.","journal-title":"Chest"},{"key":"2816_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccm.2016.12.004","volume":"38","author":"TJ Bledsoe","year":"2017","unstructured":"Bledsoe TJ, Nath SK, Decker RH. Radiation pneumonitis. Clin Chest Med. 2017;38:201\u20138.","journal-title":"Clin Chest Med"},{"key":"2816_CR39","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0360-3016(02)02929-2","volume":"54","author":"ED Yorke","year":"2002","unstructured":"Yorke ED, Jackson A, Rosenzweig KE, Merrick SA, Gabrys D, Venkatraman ES, et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys. 2002;54:329\u201339.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2816_CR40","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S0360-3016(02)02803-1","volume":"53","author":"Y Seppenwoolde","year":"2002","unstructured":"Seppenwoolde Y, Shirato H, Kitamura K, Shimizu S, van Herk M, Lebesque JV, et al. Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy. Int J Radiat Oncol Biol Phys. 2002;53:822\u201334.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2816_CR41","doi-asserted-by":"publisher","first-page":"7426","DOI":"10.1158\/1078-0432.CCR-04-2634","volume":"11","author":"M Ozsahin","year":"2005","unstructured":"Ozsahin M, Crompton NE, Gourgou S, Kramar A, Li L, Shi Y, et al. CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients. Clin Cancer Res. 2005;11:7426\u201333.","journal-title":"Clin Cancer Res"},{"key":"2816_CR42","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1080\/095530099140276","volume":"75","author":"W Westermann","year":"1999","unstructured":"Westermann W, Sch\u00f6bl R, Rieber EP, Frank KH. Th2 cells as effectors in postirradiation pulmonary damage preceding fibrosis in the rat. Int J Radiat Biol. 1999;75:629\u201338.","journal-title":"Int J Radiat Biol"},{"key":"2816_CR43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1748-717X-9-98","volume":"9","author":"F Wirsd\u00f6rfer","year":"2014","unstructured":"Wirsd\u00f6rfer F, Cappuccini F, Niazman M, de Leve S, Westendorf AM, L\u00fcdemann L, et al. Thorax irradiation triggers a local and systemic accumulation of immunosuppressive CD4+ FoxP3+ regulatory T cells. Radiat Oncol. 2014;9:98.","journal-title":"Radiat Oncol"},{"key":"2816_CR44","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ijrobp.2004.12.023","volume":"62","author":"Z Kocak","year":"2005","unstructured":"Kocak Z, Evans ES, Zhou SM, Miller KL, Folz RJ, Shafman TD, et al. Challenges in defining radiation pneumonitis in patients with lung cancer. Int J Radiat Oncol Biol Phys. 2005;62:635\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-024-02816-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-024-02816-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-024-02816-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T14:33:35Z","timestamp":1724423615000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-024-02816-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["2816"],"URL":"https:\/\/doi.org\/10.1007\/s00595-024-02816-y","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"22 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}